News | January 23, 2025
Neuland Labs board approves Capex of Rs. 342 Cr
The company plans to fund this Capex through debt and internal accruals and expects the project to be completed by FY27
The company plans to fund this Capex through debt and internal accruals and expects the project to be completed by FY27
Neuland Laboratories has reported total income of Rs. 315.17 crores during the period ended September 30, 2024
The inspections concluded with no Form 483 observations or significant critical findings
The new brand identity embodies Neuland's unwavering commitment to innovation, integrity, collaboration, and progress
Neuland Laboratories has reported total income of Rs. 390.36 crores during the period ended March 31, 2024
The inspection at Unit 1 by the USFDA has been successfully completed, with no observations under Form 483
Cipla has received 8 inspectional observations in Form 483
He brings over 30 years of experience across various organizations such as Asian Paints PPG, Berger Paints, Tata Steel, among others
Menon has over 41 years of diverse experience in some of the premier multinational and Indian companies in the chemical and power industry
Neuland Laboratories reported an uptick in peptide-related engagements from Japanese companies, particularly at the preclinical and early clinical stages
Subscribe To Our Newsletter & Stay Updated
